Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus-Reference-Cited by-同舟云学术

Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

Published:2014-11 Issue:48 Volume:32 Page:6527-6536
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lakhashe Samir K.,Byrareddy Siddappa N.,Zhou Mingkui,Bachler Barbara C.,Hemashettar Girish,Hu Shiu-Lok,Villinger Francois,Else James G.,Stock Shannon,Lee Sandra J.,Vargas-Inchaustegui Diego A.,Cofano Egidio Brocca,Robert-Guroff Marjorie,Johnson Welkin E.,Polonis Victoria R.,Forthal Donald N.,Loret Erwann P.,Rasmussen Robert A.,Ruprecht Ruth M.

Funder

NIH

National Cancer Institute

NCRR

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference64 articles.

1. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool Karim;Science,2010

2. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N. Engl. J. Med.,2010

3. Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa;Wamai;J. Int. AIDS Soc.,2011